Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GLIOTENZIDE 20 TABLET - HSA Drug Approval Details

Approvals/HSA/GLIOTENZIDE 20 TABLET

Approved

THERAPEUTIC

GLIOTENZIDE 20 TABLET

LABORATORIOS BAGO SA (ARGENTINA)🇸🇬 Health Sciences Authority

Approval Date: Jan 14, 2005
Approval ID: 87860eb352e26da5
Company: LABORATORIOS BAGO SA (ARGENTINA)
Type: Therapeutic

Approval Details

Approval Id: 87860eb352e26da5
Drug Name: GLIOTENZIDE 20 TABLET
Product Name: GLIOTENZIDE 20 TABLET
Approval Number: SIN12641P
Approval Date: 2005-01-14
Registrant: ZYFAS PHARMA PTE LTD
Licence Holder: ZYFAS PHARMA PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: C09BA02
Atc Item Name: enalapril and diuretics
Pharma Manufacturer Name: ZYFAS PHARMA PTE. LTD.
Company Detail Path: /organization/zyfas-pharma-pte-ltd

Active Ingredients

ENALAPRIL MALEATE USP

20 mg

HYDROCHLOROTHIAZIDE USP

12.5 mg

ENALAPRIL MALEATE USP

20 MG

HYDROCHLOROTHIAZIDE USP

12.5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 14, 2005

Approval ID

87860eb352e26da5

Type

Therapeutic

Back to HSA Approvals